Print This Page

August 8, 2015

Malaysia

Accounting for Most of FDA’s Antibiotic Rejections

 

The Food and Drug Administration (FDA) has increased its antibiotic inspections of imported shrimp, and it’s finding that Malaysia is one of the biggest violators.

 

In July 2015, FDA refused 58 shrimp line items from Malaysia because of antibiotic residues, over triple the amount of refusals in the same month in 2014.   Coincidentally, the bulk of Malaysia’s shrimp rejections in 2014 also occurred in July.

 

Malaysia’s shrimp refusal figures are more striking when added up for the year.  FDA has rejected 234 line items of shrimp from Malaysia since January, over eight times the amount of shipments it kicked backed in 2014.

 

Through July 2015, FDA has rejected a total of 342 line items of shrimp, and Malaysia accounted for about 70 percent of them.  During the same period in 2014, it accounted for about 15 percent of 161 total rejections.

 

Major USA shrimp suppliers India and Vietnam had 73 antibiotic refusals in the first half of 2015.  Last year at this time they had 70.  Together, the two countries accounted for about 30 percent of total USA shrimp imports through the first half of 2015, and Malaysia accounted for just 2.5 percent.

 

During the first half of 2015, FDA shrimp refusals were over double what they were a year ago.  Malaysian shipments were squarely responsible for this increase, since rejections from the major shrimp exporters to the USA are practically unchanged from 2014.

 

Source: Seafood.com (an online, subscription-based, fisheries news service).  Editor and Publisher, John Sackton (phone 1-781-861-1441, email jsackton@seafood.com).  Malaysian Shrimp Shipments Clearly on FDA’s Antibiotic Radar, Accounting for 70% of Refusals in 2015.  Michael Ramsingh (phone 1-732-240-5330, email michaelramsingh@seafood.com).  August 7, 2015.

Print This Page